Skip to main content
Caplight Logo









IDELYO

IDELYO

Private
ParisHealthcare & Life Scienceshttps://www.inzee.care/

Last Round

Corporate Funding

Jul 1, 2017

Company Overview

IDELYO operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Corporate Funding round in July 2017.

IDELYO is a health technology company that operates the inzee.care platform, which connects patients and independent healthcare professionals to facilitate home-based care and medical services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IDELYO Comparables

Compare IDELYO with similar companies based on industry and business-model similarity.

IDELYO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medicalib
84%
Libheros
83%
Gudule
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IDELYO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJul 1, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

IDELYO Investors

Notable investors and investment history

IDELYO investors
InvestorRounds
Fédération Nationale des InfirmiersCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 50% MoM, reaching over 100K.

  • Oct 30, 2024

    Monthly visitors grew 44% MoM, reaching 47.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

IDELYO Filings

Explore SEC and related filing metadata, where available.

IDELYO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IDELYO's valuation, stock price, and market status.

Is IDELYO a public or private company?

IDELYO is a private company.

What is the current stock price of IDELYO?

IDELYO is a private company, so its shares have no public market price. Caplight tracks IDELYO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IDELYO worth (valuation)?

Valuation information for IDELYO is not publicly available.

Can I buy IDELYO stock?

IDELYO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IDELYO's last funding round?

IDELYO's most recent funding round was Corporate Funding on July 1, 2017.

Who are the main investors in IDELYO?

Key investors in IDELYO include Fédération Nationale des Infirmiers.

Will IDELYO IPO soon?

No public IPO plans have been announced for IDELYO.

How can I track IDELYO secondary market activity?

Caplight tracks bids, offers, and trades in IDELYO's shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range3
Year Founded2015
Last FundingJul 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?